0 Évaluations

ID

15592

Description

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00046514

Lien

https://clinicaltrials.gov/show/NCT00046514

Mots-clés

  1. 04/06/2016 04/06/2016 -
Téléchargé le

4 juin 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Breast Neoplasms NCT00046514

    Eligibility Breast Neoplasms NCT00046514

    Criteria
    Description

    Criteria

    if female, non-pregnant and not lactating, with a negative serum pregnancy test, and either not of child-bearing potential or practicing an approved contraception method
    Description

    negative serum pregnancy test

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0430061
    eighteen years of age or older
    Description

    age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    karnofsky perfomance status of 70% or 0-2 swog performance status
    Description

    karnofsky perfomance status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0206065
    no other malignancy, except non-melanoma skin cancer, cin, or in-situ cervical cancer
    Description

    no other malignancy

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0006826
    UMLS CUI [1,2]
    C0205394
    measurable disease
    Description

    measurable disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    suitable candidate for treatment with paclitaxel
    Description

    treatment with paclitaxel

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0144576
    UMLS CUI [1,2]
    C0332149
    previously treated with taxol weekly or every three weeks, including adjuvant therapy, for metastatic breast cancer and relapsed within 12 months
    Description

    previously treated with taxol

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0144576
    if, at baseline, patient has absolute neutrophil count of at least 1500 cells/mm3, platelet count of at least 100,000 cells/mm3,and hemoglobin of at least 9 g/dl
    Description

    blood

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019046
    UMLS CUI [2]
    C0948762
    UMLS CUI [3]
    C0005821
    if, at baseline, patient has ast and alt of less than or equal to 2.5 x the upper limit of normal range; a total bilirubin less than or equal to 1.5 mg/dl; creatinine levels less than or equal to 2 mg/dl; and alkaline phosphatase levels less than or equal to 5 x the upper limit of normal range (unless there are bone but not liver metastases)
    Description

    blood measurements baseline

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    UMLS CUI [2]
    C0201899
    UMLS CUI [3]
    C0201836
    UMLS CUI [4]
    C0201850
    UMLS CUI [5]
    C0201976
    patient has an expected survival of at least 12 weeks
    Description

    expected survival

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    patient or his/her representative has signed an informed consent statement
    Description

    informed consent

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0021430

    Similar models

    Eligibility Breast Neoplasms NCT00046514

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    negative serum pregnancy test
    Item
    if female, non-pregnant and not lactating, with a negative serum pregnancy test, and either not of child-bearing potential or practicing an approved contraception method
    boolean
    C0430061 (UMLS CUI [1])
    age
    Item
    eighteen years of age or older
    boolean
    C0001779 (UMLS CUI [1])
    karnofsky perfomance status
    Item
    karnofsky perfomance status of 70% or 0-2 swog performance status
    boolean
    C0206065 (UMLS CUI [1])
    no other malignancy
    Item
    no other malignancy, except non-melanoma skin cancer, cin, or in-situ cervical cancer
    boolean
    C0006826 (UMLS CUI [1,1])
    C0205394 (UMLS CUI [1,2])
    measurable disease
    Item
    measurable disease
    boolean
    C1513041 (UMLS CUI [1])
    treatment with paclitaxel
    Item
    suitable candidate for treatment with paclitaxel
    boolean
    C0144576 (UMLS CUI [1,1])
    C0332149 (UMLS CUI [1,2])
    previously treated with taxol
    Item
    previously treated with taxol weekly or every three weeks, including adjuvant therapy, for metastatic breast cancer and relapsed within 12 months
    boolean
    C0144576 (UMLS CUI [1])
    blood
    Item
    if, at baseline, patient has absolute neutrophil count of at least 1500 cells/mm3, platelet count of at least 100,000 cells/mm3,and hemoglobin of at least 9 g/dl
    boolean
    C0019046 (UMLS CUI [1])
    C0948762 (UMLS CUI [2])
    C0005821 (UMLS CUI [3])
    blood measurements baseline
    Item
    if, at baseline, patient has ast and alt of less than or equal to 2.5 x the upper limit of normal range; a total bilirubin less than or equal to 1.5 mg/dl; creatinine levels less than or equal to 2 mg/dl; and alkaline phosphatase levels less than or equal to 5 x the upper limit of normal range (unless there are bone but not liver metastases)
    boolean
    C1278039 (UMLS CUI [1])
    C0201899 (UMLS CUI [2])
    C0201836 (UMLS CUI [3])
    C0201850 (UMLS CUI [4])
    C0201976 (UMLS CUI [5])
    expected survival
    Item
    patient has an expected survival of at least 12 weeks
    boolean
    C0023671 (UMLS CUI [1])
    informed consent
    Item
    patient or his/her representative has signed an informed consent statement
    boolean
    C0021430 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial